<DOC>
	<DOCNO>NCT00191386</DOCNO>
	<brief_summary>The study long-term extension study evaluate long-term safety efficacy Atomoxetine Japanese pediatric patient Attention-Deficit/Hyperactivity Disorder ( AD/HD ) .</brief_summary>
	<brief_title>Long-Term Study Atomoxetine Children With Attention-Deficit/Hyperactivity Disorder ( AD/HD )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Patients meet disease diagnostic study criterion Visit 2 previous placebocontrolled study , complete study Patients wish enter study Patients whose family anticipate move outside geographic range investigative site , plan extend travel inconsistent recommend visit interval</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>December 2010</verification_date>
</DOC>